Abstract
The present experiments were designed to evaluatein vivo the differential sensitivity of tumor cell subpopulations to hormone and polyamine manipulations using the hormone-responsive N-nitrosomethyl-urea (NMU)-induced rat mammary tumor. NMU tumor bearing rats were randomly assigned to control, ovariectomy, α-difluoromethyl-ornithine (DFMO) administration (an inhibitor of polyamine biosynthesis), or combination treatment, and were sacrificed on day 2, 4, or 7. The proportion of different cells was estimated by morphometric analysis and their replicative activities by [3H]-thymidine autoradiography.
In tumors of intact rats, the fractions of glandular, myoepithelial, and non-epithelial cells were 85.3 ± 2.2%, 4.7 ± 0.7%, and 9.9 ± 1.9%, respectively. Ovariectomy induced a similar time-dependent decline in the labelling indices of each cell type (from 5% to 1%). It also decreased the fraction of glandular cells (74.9 ± 4.5%), while increasing the fraction of myoepithelial (8.6 ± 1.9%) and non-epithelial (16.3 ± 3.2%) cells. DFMO exerted similar but more modest effects. DFMO-induced tumor regression was also inferior to that observed with ovariectomy. Combined ovariectomy and DFMO induced a faster and greater suppression of all labelling indices than the individual treatments, even though tumor regression was not superior to that produced by ovariectomy alone. Combination treatment also produced more profound morphologic changes, reducing the fraction of glandular cells to 64.4 ± 3.9% and increasing that of non-epithelial cells to 26.6 ± 4.4%. Ovariectomy and DFMO reduced height but not width of glandular cells, resulting in a modest decrease in cell volume. The combination treatment, however, significantly suppressed all three parameters.
Cellular levels of polyamines were only modestly affected by the treatment used, thus raising doubts on their role as mediators, at least of ovariectomy-induced effects. Nevertheless, these results emphasize the sensitivity of different cell components of NMU tumors to combined hormone and anti-polyamine therapy with regard to kinetic and morphometric changes.
References
Manni A, Wright C: Polyamines as mediators of estrogen action on the growth of experimental breast cancer in rats. J Natl Cancer Inst 73: 511–514, 1984
Manni A, Wright C: Polyamines as mediators of the effect of prolactin and growth hormone on the growth of N-nitroso-N-methylurea-induced rat mammary tumor culturedin vitro in soft agar. J Natl Cancer Inst 74: 941–944, 1985
Manni A, Badger B, Wright C, Ahmed SR, Demers L: Effects of progestins on growth of experimental breast cancer in culture: Interaction with estradiol and prolactin and involvement of the polyamine pathway. Cancer Res 47: 3066–3071, 1987
Lima G, Shiu RPC: Role of polyamines in estradiol-induced growth of human breast cancer cells. Cancer Res 45: 2466–2470, 1985
Kenda KL, Katzenellenbogen BS: An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone receptor levels by estrogen and antiestrogen. J Steroid Biochem 28: 123–128, 1987
Manni A, Badger B, Luk G, Wright C, Caplan R, Rockette H, Bartholomew M, Ahmed SR: Role of polyamines in the growth of hormone-responsive experimental breast cancerin vivo. Breast Cancer Res Treat 11: 231–240, 1988
Manni A, Badger B: Selectivity of polyamine involvement in hormone action in normal and neoplastic endocrine target tissues. 71st Annual Meeting of the Endocrine Society, June 21–24, 1989, p 93 (Abstract # 284)
Lancaster S, English HF, Demers LM, Manni A: Kinetic and morphometric responses of heterogeneous populations of experimental breast cancer cellsin vivo. Cancer Res 48: 3276–3281, 1988
Arafah BM, Finegan HM, Roe J, Manni A, Pearson O: Hormone dependency in N-nitrosomethylurea-induced rat mammary tumors. Endocrinology 111: 584–588, 1982
Seiler N, Knodgen B: High performance liquid chromatographic procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives. J Chromat 221: 227–235, 1980
Manni A, Badger B, Glikman P, Bartholomew M, Santner S, Demers L: Individual and combined effects of α-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats. Cancer Res 49: 3529–3534, 1989
Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759–774, 1988
Russell DH, Gullino PM, Marton LJ, LeGendre SM: Polyamine depletion of the MTW9 mammary tumor and subsequent elevation of spermidine in the sera of tumor-bearing rats as a biochemical marker of tumor regression. Cancer Res 34: 2378–2381, 1974
Manni A, Wright C, Demers L, Luk G: Polyamines and hormonal regulation of N-nitrosomethylurea-induced rat mammary tumor growthin vivo. Cancer Res 46: 4938–4941, 1986
Lippman ME, Cassidy J, Wesley M, Young RC: A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization. J Clin Oncol 2: 28–36, 1984
Conte PF, Pronzato A, Rubagotti A,et al: Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: Results of a randomized cooperative trial. J Clin Oncol 5: 339–347, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manni, A., Lancaster, S., English, H. et al. Kinetic and morphometric responses of heterogeneous populations of NMU-induced rat mammary tumor cells to hormone and antipolyamine therapyin vivo . Breast Cancer Res Tr 17, 179–186 (1991). https://doi.org/10.1007/BF01806367
Issue Date:
DOI: https://doi.org/10.1007/BF01806367